A Medical Journal Rejected RFK Jr.'s Vaccine Study Retraction Request—Here's Why It Matters
A Medical Journal Rejected RFK Jr.'s Vaccine Study Retraction Request—Here's Why It Matters
The Annals of Internal Medicine has refused a request from Health and Human Services Secretary Robert F. Kennedy Jr. to withdraw a major Danish study on aluminum in vaccines. The journal's editor-in-chief told Reuters in August 2025 that she saw "no reason" to pull the paper.
The Danish study examined health records from 1.2 million people and found that aluminum — an ingredient added to many vaccines to boost immune response — does not increase health risks in children. Aluminum salts are common in vaccines worldwide; they work by strengthening how well the body responds to the shot, which allows doctors to use smaller doses of the active ingredient. Kennedy pushed for the paper to be retracted, but the journal declined.
Retracting published research is a formal process. Journals pull papers when they find fabrication, data manipulation, or serious errors in the research itself — not when a government official disagrees with the conclusions. The Annals followed that standard practice. The editor's response made her position clear.
What makes this episode significant is the collision between Kennedy's long-standing concerns about vaccine safety and his current job as the nation's top health official. The Secretary of Health and Human Services oversees three major agencies — the CDC, the FDA, and the NIH — that conduct and share scientific research. These agencies depend on their reputation for independence to keep their work credible. When a cabinet secretary questions published research, it raises a question about whether political pressure could influence science.
Kennedy's plans to reorganize HHS by combining several separate programs under one structure have already drawn attention from researchers and journal editors. Some worry that consolidating these programs could expose scientific work to political influence. The retraction request sits in that context — it's one sign observers are watching to understand how the department may change.
From the perspective of scientific publishers, the Annals response is textbook editorial independence. Journals face pressure regularly — from companies, governments, advocacy groups — to reconsider findings that don't fit someone's interests. What is unusual here is who applied the pressure: a sitting cabinet secretary who controls the funding that flows to universities and research centers whose scientists publish in journals like the Annals. The editor-in-chief's refusal signals that the journal will treat such requests the same way it treats any other unsupported demand for retraction.
The open question is what Kennedy does next. He cannot directly regulate scientific journals. But his department controls funding: NIH grants, CDC agreements, and HHS contracts that go to academic institutions. If that funding becomes conditional on favorable research outcomes, or if Congress or other institutions fail to object, it would signal something important about whether scientific independence can survive political pressure in this administration. Whether it happens — and how institutions respond if it does — will say more than this single exchange can.
Key Context
Aluminum adjuvants have been studied extensively. Peer-reviewed journals have published hundreds of papers on vaccine ingredients; regulators worldwide have evaluated them. Kennedy's skepticism of vaccines is long-standing and public, predating his government role. The clash between his personal views and his official responsibility for health agencies without expressing those doubts is what makes this moment so closely watched.
